---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-081588"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2026-07-08T12:32:50+00:00"
generated_at: "2026-07-08T12:35:06.485622+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Esperion shareholders approve merger with Essence Parent Inc.

## Summary
- Merger Agreement approved with 135,326,793 votes for, 22,750,628 against, 496,194 abstentions.
- Advisory compensation proposal approved with 129,937,383 votes for, 22,283,787 against, 6,352,445 abstentions.
- Quorum of 61.53% of outstanding shares represented at July 8, 2026 special meeting.
- MergerCo will merge into Esperion, which will survive as wholly owned subsidiary of Parent.

## SEC filing metadata
- accession: 0001104659-26-081588
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2026-07-08T12:32:50+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/0001104659-26-081588-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465926081588/tm2620034d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-081588
- JSON: https://secwatch.observer/filing/0001104659-26-081588.json
- Plain text: https://secwatch.observer/filing/0001104659-26-081588.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.